Edgewise Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.About EWTX
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.
CEOKevin Koch
CEOKevin Koch
Employees110
Employees110
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2017
Founded2017
Employees110
Employees110
EWTX Key Statistics
Market cap2.51B
Market cap2.51B
Price-Earnings ratio-15.03
Price-Earnings ratio-15.03
Dividend yield—
Dividend yield—
Average volume1.13M
Average volume1.13M
High today$24.00
High today$24.00
Low today$23.14
Low today$23.14
Open price$23.44
Open price$23.44
Volume931.35K
Volume931.35K
52 Week high$35.50
52 Week high$35.50
52 Week low$10.60
52 Week low$10.60
Stock Snapshot
Edgewise Therapeutics(EWTX) stock is priced at $23.71, giving the company a market capitalization of 2.51B. It carries a P/E multiple of -15.03.
On 2025-12-04, Edgewise Therapeutics(EWTX) stock moved within a range of $23.14 to $24.00. With shares now at $23.71, the stock is trading +2.5% above its intraday low and -1.2% below the session's peak.
Trading volume for Edgewise Therapeutics(EWTX) stock has reached 931.35K, versus its average volume of 1.13M.
The stock's 52-week range extends from a low of $10.60 to a high of $35.50.
The stock's 52-week range extends from a low of $10.60 to a high of $35.50.
Analyst ratings
83%
of 12 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own EWTX. This list is generated using Robinhood data, and it’s not a recommendation.